Valion Bio (TIVC) Depreciation & Amortization (CF) (2021 - 2025)
Valion Bio has reported Depreciation & Amortization (CF) over the past 5 years, most recently at $3000.0 for Q4 2025.
- For Q4 2025, Depreciation & Amortization (CF) changed N/A year-over-year to $3000.0; the TTM value through Dec 2025 reached $5000.0, up 66.67%, while the annual FY2025 figure was $5000.0, 66.67% up from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 was $3000.0 at Valion Bio, up from $1000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $3000.0 in Q3 2022 and troughed at $1000.0 in Q3 2023.
- A 5-year average of $1888.9 and a median of $2000.0 in 2021 define the central range for Depreciation & Amortization (CF).
- Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 50.0% in 2022 and later plummeted 66.67% in 2023.
- Year by year, Depreciation & Amortization (CF) stood at $2000.0 in 2021, then skyrocketed by 50.0% to $3000.0 in 2022, then crashed by 33.33% to $2000.0 in 2023, then plummeted by 50.0% to $1000.0 in 2024, then surged by 200.0% to $3000.0 in 2025.
- Business Quant data shows Depreciation & Amortization (CF) for TIVC at $3000.0 in Q4 2025, $1000.0 in Q2 2025, and $1000.0 in Q1 2025.